Huons Global Co., Ltd. Logo

Huons Global Co., Ltd.

Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.

084110 | KO

Overview

Corporate Details

ISIN(s):
KR7084110006
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 9층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Global Co., Ltd. is a holding company for a total healthcare group focused on providing solutions for human health. The company's core business encompasses the research, development, manufacturing, and sale of pharmaceutical products, medical devices, cosmetics, and health-functional food components. With a history dating back to 1965, the group has notable achievements, including the development of local anesthetics. Huons Global prioritizes expanding its research and development capabilities to find new growth engines and is actively advancing its presence in the global healthcare market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정(자회사의 주요경영사항)
Korean 6.3 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정(자회사의 주요경영사항) (중간배당)
Korean 9.6 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-07 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 14.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.7 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 10.5 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.8 MB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출(자회사의 주요경영사항)
Korean 26.8 KB
2025-03-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all Huons Global Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Huons Global Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Huons Global Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Erasca, Inc. Logo
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS
Ernexa Therapeutics Inc. Logo
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP
Esperion Therapeutics, Inc. Logo
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR
ESSA Pharma Inc. Logo
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America
EPIX
Estrella Immunopharma, Inc. Logo
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America
ESLA
Eton Pharmaceuticals, Inc. Logo
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America
ETON
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea
206650
EUPRAXIA PHARMACEUTICALS INC. Logo
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America
EPRX
EuroAPI Logo
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France
EAPI

Talk to a Data Expert

Have a question? We'll get back to you promptly.